Skip to main navigation Skip to search Skip to main content

Epigenetic fragility of the endocannabinoid system under stress: Risk for mood disorders and pharmacogenomic implications

  • Bar-Ilan University
  • University of Delaware

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations
Original languageEnglish
Pages (from-to)657-660
Number of pages4
JournalEpigenomics
Volume12
Issue number8
DOIs
StatePublished - Apr 2020

Bibliographical note

Funding Information:
Research in AW’s lab is partially funded by the Israel Science Foundation, The Israel Ministry of Science and EPM, Inc. Research in TLR’s lab is funded by Grant 1R01HD087509 from the National Institute of Child Health and Human Development. These funding sources did not have any input in the content of this manuscript. Beyond the above, the authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.

Funding

Research in AW’s lab is partially funded by the Israel Science Foundation, The Israel Ministry of Science and EPM, Inc. Research in TLR’s lab is funded by Grant 1R01HD087509 from the National Institute of Child Health and Human Development. These funding sources did not have any input in the content of this manuscript. Beyond the above, the authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.

FundersFunder number
EPM, Inc.1R01HD087509
Israel Ministry of Science
National Institute of Child Health and Human Development
Israel Science Foundation

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • 2-AG
    • CB1
    • FAAH
    • anxiety
    • depression
    • endocannabinoid System
    • pharmacogenomics
    • predisposition

    Cite this